Agree Oils2006. Tom has done a fantastic job in improving the margins for the business over the years. I am unsure of Dr Verma's experience so I can't comment on that.
This is pure speculation, but what do people think of a potential sale of the iTrack business down the line to a big Pharma company?
Remember, Allergan purchased Aquesys (who own the Xen45 MIGS product) for US$300m and that was before any FDA approval (I think...). I read one of Allergan's investor presentations in the past and there was a slide that discussed the significant shift in the Glaucoma market from drops to MIGS. The growth in the MIGS market over the last couple of years is supporting this view.
Exciting times ahead!
Ann: Ellex Company Update, page-5
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.005(2.08%) |
Mkt cap ! $56.06M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 26.0¢ | 24.0¢ | $128.3K | 523.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2500 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 25000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| EYE (ASX) Chart |